Drug conjugates, also known as antibody-drug conjugates (ADCs), are a class of targeted cancer therapies designed to deliver cytotoxic agents directly to cancer cells. These agents combine the specificity of monoclonal antibodies with the potency of highly toxic drugs, aiming to maximize cancer cell kill while minimizing damage to normal tissues.
